Get the Stockscreener App
2.32
0.43%
0.010
After Hours:
2.36
0.04
+1.72%
Aethlon Medical Inc stock is traded at $2.32, with a volume of 8,878.
It is up +0.43% in the last 24 hours and up +18.97% over the past month.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
See More
Previous Close:
$2.31
Open:
$2.34
24h Volume:
8,878
Relative Volume:
0.16
Market Cap:
$3.64M
Revenue:
$574.20K
Net Income/Loss:
$-11.52M
P/E Ratio:
-0.0506
EPS:
-45.8332
Net Cash Flow:
$-6.92M
1W Performance:
+4.04%
1M Performance:
+18.97%
6M Performance:
+231.81%
1Y Performance:
+561.35%
1-Day Range:
$2.20
$2.37
1-Week Range:
$2.10
$2.38
52-Week Range:
$0.312
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
2.32 | 3.62M | 574.20K | -11.52M | -6.92M | -45.83 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | H.C. Wainwright | Neutral |
Aethlon Medical Inc Stock (AEMD) Latest News
Advancements in Novel Immunotherapeutics in The Oncology Battle - ADVFN
Fundamentals Check: Will Aethlon Medical Inc stock recover after earningsTrade Analysis Summary & High Yield Stock Recommendations - baoquankhu1.vn
US Market Wrap: Is Aethlon Medical Inc a strong growth stock2026 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
What is the fair value of Aethlon Medical Inc. stock now2026 Sector Review & Technical Pattern Based Signals - Bollywood Helpline
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Aethlon Medical Update: DSMB Clears Aussie Oncology Trial to Advance Hemopurifier to Cohort 3 - Defense World
Death Cross: How is Aethlon Medical Inc managing supply chain issues2026 Analyst Calls & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Aethlon Medical (AEMD) director forfeits 178 shares to cover RSU taxes - Stock Titan
Aethlon Medical (NASDAQ: AEMD) director forfeits 178 shares for tax withholding - Stock Titan
Director at Aethlon (NASDAQ: AEMD) forfeits shares to cover taxes - Stock Titan
Aethlon Medical : Corporate OverviewMarch 2026 - marketscreener.com
Performance Recap: Whats the profit margin of Aethlon Medical IncQuarterly Profit Report & High Accuracy Investment Entry Signals - baoquankhu1.vn
Aethlon Medical advances to final cohort in cancer device trial By Investing.com - Investing.com Australia
Market Pulse: How is Aethlon Medical Inc managing supply chain issuesWeekly Trend Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Bitget
AEMD Technical Analysis & Stock Price Forecast - Intellectia AI
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 earnings call transcript - MSN
Cancer device study moves forward after reviewers find no safety issues - Stock Titan
Novel Immunotherapeutics Stocks in the News (Nasdaq:AEMD), (Nasdaq:HURA) (NYSE: AZN) (Nasdaq: ELTX) - Investorideas.com
AEMD Trial Progress: Aethlon Medical Advances to Final Cohort - GuruFocus
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Investorideas.com
Aethlon Medical advances to final cohort in cancer device trial - Investing.com
Aug Closing: Does Aethlon Medical Inc offer margin of safetyWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn
If You Invested $1,000 in Aethlon Medical (AEMD) - Stock Titan
Aethlon Medical, Inc.: Fundamental Analysis and Financial Ratings | EJU0 | US00808Y5050 - marketscreener.com
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Aethlon Medical announces full exercise of pre-funded warrants By Investing.com - Investing.com India
Aethlon Medical announces full exercise of pre-funded warrants - Investing.com
Aethlon Medical, Inc. Announces All Pre-Funded Warrants Exercised; 1,569,110 Shares Outstanding as of March 16, 2026 - Minichart
Aethlon Medical Completes Pre-Funded Warrant Exercises, Simplifying Equity - TipRanks
All Aethlon Medical (AEMD) pre-funded warrants exercised, 1,569,110 shares out - Stock Titan
Aethlon Medical hires Maxim Group to explore strategic options - Investing.com Nigeria
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) on the Move – Morning High of $2.09 - Investorideas.com
Aethlon Medical hires Maxim Group to explore strategic options By Investing.com - Investing.com South Africa
Aethlon Medical at Life Sciences Forum: Hemopurifier’s Oncology Focus By Investing.com - Investing.com Canada
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Gains on News - Investorideas.com
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Engages Maxim Group LLC to Evaluate Strategic Opportunities - Investorideas.com
Aethlon Medical (AEMD) Explores Strategic Opportunities with Max - GuruFocus
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Cancer and infection treatment developer Aethlon explores deals with Maxim - Stock Titan
Aethlon Medical Q1 2026 Earnings Preview - MSN
Winners Losers: Is Aethlon Medical Inc showing insider buyingIPO Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Investment Review: Whats the profit margin of Aethlon Medical IncPortfolio Value Report & Verified Short-Term Plans - baoquankhu1.vn
Aethlon Medical to Present at Life Sciences Investor Forum - Intellectia AI
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th - GlobeNewswire
Energy Moves: Can Aethlon Medical Inc continue delivering strong returnsInsider Buying & Safe Capital Growth Trade Ideas - baoquankhu1.vn
AEMD SEC FilingsAethlon Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions - Benzinga
Aethlon Medical to Present at Emerging Growth Conference - Intellectia AI
Ask Aethlon Medical’s CEO and CFO live at Emerging Growth Conference - Stock Titan
Zacks Research Weighs in on Aethlon Medical FY2026 Earnings - Defense World
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):